KFI
VRCA icon

Key Financial Inc’s Verrica Pharmaceuticals VRCA Stock Holding History

Key Financial Inc’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-942
Closed -$4.99K – 1496
2025
Q2 		$4.99K Hold
942
– – ﹤0.01% 1037
2025
Q1 		$4.16K Hold
942
– – ﹤0.01% 1031
2024
Q4 		$6.59K Hold
942
– – ﹤0.01% 913
2024
Q3 		$13.7K Hold
942
– – ﹤0.01% 721
2024
Q2 		$68.6K Buy
+942
New +$72.4K 0.02% 408

Other funds holding VRCA

CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SA
Sovran Advisors San Diego, California $1.27B AUM 18.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return

Key Financial Inc's VRCA Position: Q3 2025 in Review

Key Financial Inc sold out of Verrica Pharmaceuticals (VRCA) in Q3 2025, closing a stake of 942 shares — an estimated $4.99K sold.

Key Financial Inc first reported a position in VRCA in Q2 2024 and held it in 5 quarters. The position peaked at $68.6K in Q2 2024. 34 funds tracked by Wall St. Rank hold VRCA as of Q3 2025.

  • Key Financial Inc reported no remaining Verrica Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Key Financial Inc sold 942 Verrica Pharmaceuticals shares in Q3 2025, an estimated $4.99K.
  • Key Financial Inc first reported a position in Verrica Pharmaceuticals in Q2 2024 and held it in 5 quarters.
  • Key Financial Inc's Verrica Pharmaceuticals position peaked at $68.6K in Q2 2024.
  • 34 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q3 2025.

Based on Key Financial Inc's 13F filing for Q3 2025, filed 5 Nov 2025.